GlassScriptPhysician profile
Mark Michaels Levin
NPI 1730492414
$13,484.11
in general payments reported to CMS, 2019-2025
29 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,151 · 2020: $407 · 2021: $474 · 2022: $1,107 · 2023: $8,839 · 2024: $331 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $6,417 · Food and Beverage: $1,791 · Travel and Lodging: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $6,416.67 |
| Food and Beverage | $1,790.98 |
| Travel and Lodging | $1,138.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $8,143.81 | 2019-2024 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $1,671.26 | 2019-2023 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft |
| Silk Road Medical, INC. | $610.50 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $600.58 | 2019-2025 | Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $434.26 | 2022 | |
| Cook Medical LLC | $404.18 | 2019-2023 | Zenith Alpha, Zenith |
| Medtronic, INC. | $273.91 | 2021-2023 | Abre |
| Atricure, INC. | $140.71 | 2024-2025 | Atriclip Laa Exclusion System |
| Cardiovascular Systems INC. | $137.90 | 2020-2022 | |
| Amniox Medical, INC. | $133.03 | 2020 | |
| Medtronic Vascular, INC. | $96.92 | 2019 | |
| Edwards Lifesciences Corporation | $86.61 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal |
| Inari Medical, INC. | $78.49 | 2021 | |
| Lemaitre Vascular, INC. | $69.70 | 2021-2024 | Artegraft Vascular Graft, Xenosure Biologic Patch |
| Cardiva Medical, INC. | $69.13 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $60.48 | 2020-2022 | |
| Terumo Medical Corporation | $56.62 | 2020 | |
| Shockwave Medical, INC | $52.16 | 2022 | |
| Janssen Pharmaceuticals, INC | $52.15 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $49.54 | 2023 | Opsumit, Uptravi |
| Abbott Laboratories | $48.70 | 2020-2023 | Diamondback Peripheral |
| Penumbra, INC. | $37.80 | 2023 | Indigo System |
| Organogenesis INC. | $33.41 | 2023 | Puraply |
| Alnylam Pharmaceuticals INC. | $33.25 | 2024 | Onpattro |
| Elutia, INC. | $25.94 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.75 | 2023 | Farxiga |
| Scpharmaceuticals INC. | $22.58 | 2024 | |
| Mimedx Group, INC. | $18.75 | 2025 | |
| Merck Sharp & Dohme LLC | $17.99 | 2024 | Winrevair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.